Upgrade to SI Premium - Free Trial

NeOnc Technologies Holdings (NTHI)

5.03 +0.24 (5.01%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/13/26)

Latest Headlines

NeOnc reports Phase 2a brain cancer trial results, plans FDA meeting August 28, 2026 10:08 AM - StreetInsider NeOnc’s Phase 2A Success Could Set the Stage for Something Much Bigger August 28, 2026 10:07 AM - Globe NewsWire NeOnc’s Clinical Story Is Now the Main Event August 26, 2026 9:39 AM - Globe NewsWire Form 8-K/A NEONC TECHNOLOGIES HOLDI For: Jun 27 August 21, 2026 2:59 PM - SEC Filing Form 4 NEONC TECHNOLOGIES HOLDI For: Aug 18 Filed by: CHEN THOMAS C August 20, 2026 9:16 PM - SEC Filing Form 4/A NEONC TECHNOLOGIES HOLDI For: Apr 10 Filed by: CHEN THOMAS C August 20, 2026 9:15 PM - SEC Filing Form 8-K NEONC TECHNOLOGIES HOLDI For: Aug 14 August 20, 2026 9:00 AM - SEC Filing Form 4 NEONC TECHNOLOGIES HOLDI For: Apr 09 Filed by: CHEN THOMAS C August 18, 2026 4:14 PM - SEC Filing Form 4 NEONC TECHNOLOGIES HOLDI For: Aug 18 Filed by: Heshmatpour Amir F August 18, 2026 2:31 PM - SEC Filing NeOnc Technologies- Talk Is Cheap, Insider Buying Isn’t August 18, 2026 10:18 AM - Globe NewsWire Form 4 NEONC TECHNOLOGIES HOLDI For: Aug 14 Filed by: Heshmatpour Amir F August 17, 2026 6:50 PM - SEC Filing These Nasdaq Stories Are Heating Up August 17, 2026 3:27 PM - StreetInsider NTHI’s Nasdaq Advantage Takes on New Meaning After Its Breakthrough Phase 2a Results August 17, 2026 8:45 AM - Globe NewsWire New to The Street Airs This Weekend Across Bloomberg Television U.S., Latin America and MENA August 15, 2026 10:41 AM - StreetInsider These Biotech Breakouts and Squeeze Setups Could Be Just Getting Started August 14, 2026 1:14 PM - StreetInsider Form 8-K NEONC TECHNOLOGIES HOLDI For: Aug 12 August 13, 2026 5:21 PM - SEC Filing Stonegate Capital Partners Updates Coverage on NeOnc Technologies Holdings, Inc. (NTHI) 2Q26 August 13, 2026 4:20 PM - StreetInsider The Nose Knows: Why NeOnc’s Patent Portfolio Could Make NTHI More Than a One-Drug Biotech August 13, 2026 2:31 PM - Globe NewsWire Powerful Catalysts Sending These Stocks into High Gear August 12, 2026 2:11 PM - StreetInsider Targeting The Mutant: NTHI’s NEO100 Data Could Open a New Front in the Fight Against Brain Cancer August 12, 2026 9:38 AM - Globe NewsWire NeOnc Phase 2a brain cancer trial shows 48.9% survival vs. 20% benchmark August 12, 2026 9:27 AM - StreetInsider NeOnc's NEO100 Phase 2a Brain Cancer Study Beats Historical Benchmark by Nearly 2.5x August 12, 2026 9:27 AM - StreetInsider Form 8-K NEONC TECHNOLOGIES HOLDI For: Aug 12 August 12, 2026 8:32 AM - SEC Filing NeOnc phase 2a trial of intranasal NEO100 meets primary endpoint August 12, 2026 8:00 AM - StreetInsider NeOnc Technologies Reports Positive Topline Phase 2a Results for Intranasal NEO100 in Recurrent IDH1-Mutant High-Grade Glioma August 12, 2026 8:00 AM - StreetInsider NeOnc Technologies Holdings (NTHI) Halted, News Pending August 12, 2026 7:55 AM - StreetInsider These Have the Market Hot Zone Catalysts and Setups August 11, 2026 4:52 PM - StreetInsider Breakout Stocks and Next Big Movers Could Be Taking Shape Now August 11, 2026 2:45 PM - StreetInsider NeOnc Approaches a Major Biotech Inflection Point as tomorrow’s Brain-Cancer Data is set to Collide with a Tight Float August 11, 2026 11:01 AM - StreetInsider NTHI Brain Cancer Phase 2 Data Expected to Spark Triple Confluence August 11, 2026 8:46 AM - StreetInsider Form 8-K NEONC TECHNOLOGIES HOLDI For: Aug 10 August 10, 2026 5:15 PM - SEC Filing NeOnc Technologies Holdings (NTHI) Reports Q2 Loss of $0.58 August 10, 2026 4:16 PM - StreetInsider The Catalysts are Back: Socket Mobile Breaks Out while Biotechs Race Toward Major Milestones August 10, 2026 10:40 AM - StreetInsider NeOnc to release NEO100 Phase 2a trial data on August 12 August 10, 2026 10:34 AM - StreetInsider NeOnc Heads into a High-Stakes Week as Highly Anticipated NEO100 Phase 2a Data Readout Nears August 10, 2026 10:34 AM - Globe NewsWire Form 10-Q NEONC TECHNOLOGIES HOLDI For: Jun 30 August 10, 2026 9:01 AM - SEC Filing NeOnc posts wider Q2 loss, plans NEO100 trial data release Aug. 12 August 10, 2026 9:00 AM - StreetInsider NeOnc Reports Second Quarter 2026 Financial Results and Confirms August 12 Topline Phase 2a NEO100 Data Readout August 10, 2026 9:00 AM - StreetInsider NeOnc Technologies to discuss Phase 2a glioma trial results Aug. 12 August 10, 2026 8:30 AM - StreetInsider NeOnc Technologies to Host Investor Conference Call to Discuss Topline Phase 2a Results for Intranasal NEO100 in Recurrent IDH1-Mutant High-Grade Glioma August 10, 2026 8:30 AM - StreetInsider Why Investors Are Watching These Healthcare Movers August 6, 2026 12:32 PM - StreetInsider NeOnc Technologies adds strategy executive Nasim Shomali to its board July 27, 2026 9:00 AM - StreetInsider NeOnc Technologies Appoints Strategy and Finance Executive Nasim Shomali to its Board of Directors July 27, 2026 9:00 AM - StreetInsider Three Biotechs Deliver Catalysts to Watch July 15, 2026 10:43 AM - StreetInsider Form 8-K NEONC TECHNOLOGIES HOLDI For: Jul 15 July 15, 2026 9:15 AM - SEC Filing NeOnc gets FDA manufacturing feedback for NEO212 tablet transition July 15, 2026 9:02 AM - StreetInsider NeOnc Receives FDA Written Feedback on NEO212 CMC Development and Capsule-to-Tablet Transition July 15, 2026 9:00 AM - StreetInsider Form 4 NEONC TECHNOLOGIES HOLDI For: Jul 10 Filed by: SHOMALI NASIM July 13, 2026 5:01 PM - SEC Filing Form 3 NEONC TECHNOLOGIES HOLDI For: Jul 01 Filed by: SHOMALI NASIM July 13, 2026 5:00 PM - SEC Filing Form 8-K NEONC TECHNOLOGIES HOLDI For: Jun 27 July 2, 2026 5:12 PM - SEC Filing Wall Street is Watching These Biotechs July 1, 2026 9:33 AM - StreetInsider Form D NEONC TECHNOLOGIES HOLDI June 25, 2026 5:00 PM - SEC Filing The New War on Cancer: Four Public Companies Helping Lead a Medical Revolution June 25, 2026 11:40 AM - StreetInsider NeOnc Ignites Explosive Summer: 4 New Research Reports + UAE/Dubai Drug Approval Fuel Breakout Momentum June 24, 2026 8:45 AM - StreetInsider Form EFFECT NEONC TECHNOLOGIES HOLDI June 24, 2026 6:03 AM - SEC Filing Form DEFA14A NEONC TECHNOLOGIES HOLDI June 23, 2026 5:10 PM - SEC Filing Form DEF 14A NEONC TECHNOLOGIES HOLDI For: Aug 14 June 23, 2026 5:09 PM - SEC Filing Form 8-K NEONC TECHNOLOGIES HOLDI For: Jun 23 June 23, 2026 5:00 PM - SEC Filing Form 424B5 NEONC TECHNOLOGIES HOLDI June 23, 2026 5:00 PM - SEC Filing These Emerging Companies Are Racing Toward Major Catalysts June 23, 2026 11:12 AM - StreetInsider NeOnc gets UAE approval for NEO100 brain cancer drug trials June 23, 2026 9:00 AM - StreetInsider NeOnc Technologies Receives UAE IND Approval for NEO100, Expanding Global Development Ahead of Anticipated Phase 2 Data Milestone June 23, 2026 9:00 AM - StreetInsider International Regulatory Pathways Have Supported Drug Development Across Biotech and Pharma June 22, 2026 9:05 AM - StreetInsider WSTPR Catalyst Watch: Abu Dhabi Regulatory Clearance Adds Momentum to NeOnc's Global Neuro-Oncology Strategy June 22, 2026 8:47 AM - StreetInsider Form 8-K NEONC TECHNOLOGIES HOLDI For: Jun 16 June 18, 2026 5:01 PM - SEC Filing Biotech's New Frontier: Companies Breaking Through Medicine's Toughest Barriers June 17, 2026 10:38 AM - StreetInsider NeOnc's Global Expansion Accelerates After Abu Dhabi IND Approval for NEO212 June 17, 2026 9:19 AM - StreetInsider NeOnc's Global Expansion Accelerates After Abu Dhabi IND Approval for NEO212 June 17, 2026 9:18 AM - Globe NewsWire Wall Street Chases the Next Big Breakout June 16, 2026 3:23 PM - StreetInsider Brain Cancer Innovator NeOnc Heads into Critical Data Season with Fresh Abu Dhabi IND June 16, 2026 1:49 PM - Globe NewsWire Biotech Bulls Stampede as Clinical Wins and Milestones Fuel Momentum June 16, 2026 10:19 AM - StreetInsider NeOnc gets UAE clearance for NEO212 brain tumor drug trial June 16, 2026 9:00 AM - StreetInsider NeOnc Technologies Secures UAE IND Approval for NEO212 Following Successful Phase 1 Completion, Advancing Toward Global Phase 2 Development June 16, 2026 9:00 AM - StreetInsider NeOnc Technologies Holdings (NTHI) files for 555,554 share offering by selling stockholders June 15, 2026 4:28 PM - StreetInsider Form S-3 NEONC TECHNOLOGIES HOLDI June 15, 2026 4:25 PM - SEC Filing WSTPR Catalyst Watch: NeOnc Strengthens Capital Position Ahead of Potentially Transformational Neuro-Oncology Updates June 15, 2026 8:37 AM - StreetInsider From Nokia to NeOnc: The Stocks Dominating Screens as Volume Spikes June 12, 2026 11:41 AM - StreetInsider Form 8-K NEONC TECHNOLOGIES HOLDI For: Jun 10 June 12, 2026 6:03 AM - SEC Filing Form PRE 14A NEONC TECHNOLOGIES HOLDI For: Jun 11 June 11, 2026 4:15 PM - SEC Filing The Race to Defeat Brain Cancer Could Become One of the Biggest Biotech Stories of the Decade June 9, 2026 8:47 AM - StreetInsider Full Article List